-
Use of the Glucocorticoid Toxicity Index-Metabolic Domains Instrument to Quantify Glucocorticoid Toxicity in Adults With Chronic Inflammatory Demyelinating Polyneuropathy Using Electronic Health Records in the United States
Mar 10, 2025, 14:00 PM -
Review of NICE, PBAC, and CDA HTA Outcomes For Oncology Drugs Approved by the FDA Through Project Orbis (2022-2023)
Mar 10, 2025, 14:00 PM -
Response Performance of General Chinese Children Aged 6-11 to EQ-5D-Y-3L: A Multicenter Study
Mar 10, 2025, 14:00 PM -
Patient Perspectives on Communication With Clinicians: A Survey on Hospitalized Patient Experiences
Mar 10, 2025, 14:00 PM -
What Proportion of the Total Value Generated by New Drugs Accrues to Manufacturers? A Review of Empirical Estimates of Producer Surplus
Mar 10, 2025, 14:00 PM -
Cost-Utility Analysis of Lorlatinib in First-Line Treatment of adult patients with ALK-Positive Advanced Non-Small Cell Lung Cancer (aNSCLC) in Colombia
Mar 10, 2025, 14:00 PM -
Patient Characteristics Associated with the Use of Newly Approved Disease-Modifying Therapy (DMT) for Sickle Cell Disease in Texas Medicaid
Mar 10, 2025, 14:00 PM -
Linkage Of Patient Services and Real-world Healthcare Data: A Unique Approach to Gain Insights into Factors that Impact Medication Adherence
Mar 10, 2025, 14:00 PM -
The Cost-Effectiveness of Eteplirsen vs. Standard of Care in Delaying the Progression of Duchenne Muscular Dystrophy
Mar 10, 2025, 14:00 PM -
Economic Impact of Multiplex Point-of-Care Testing for Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium: Development of a Modeling Framework
Mar 10, 2025, 14:00 PM -
Race and Ethnicity Differences in the HPV Vaccine Initiation Prompted by Electronic Reminders
Mar 10, 2025, 14:00 PM -
Challenges of Pre-Market Clinical Investigations of Medical Devices: A Multi-Stakeholder Perspective
Mar 10, 2025, 14:00 PM -
Characteristics and Adherence of Patients Initiating Injectable Cabotegravir for HIV Treatment or Prevention
Mar 10, 2025, 14:00 PM -
Analysis of NICE Assessments for Orphan Treatments and Key Drivers for Decision-Making
Mar 10, 2025, 14:00 PM -
Real-World Effectiveness of Tirzepatide vs. Semaglutide on HbA1c and Weight in GLP-1 RA Experienced Patients with T2D
Mar 10, 2025, 14:00 PM -
Racial Disparities in Biomarker Testing Rate, First-Line (1L) Treatment Patterns and Clinical Outcomes Among Real-World Patients in the United States (US) with Advanced or Metastatic Non-Small Cell Lung Cancer (mNSCLC)
Mar 10, 2025, 14:00 PM -
Prevalence of Claims-Reported Pruritus in Patients With Primary Biliary Cholangitis Overall and Among Those Treated With Obeticholic Acid
Mar 10, 2025, 14:00 PM -
Factors Delaying the Public Listing of New Drugs in Canada
Mar 10, 2025, 14:00 PM -
Payer Perceptions on Creating a National Value assessment Body in the US
Mar 10, 2025, 14:00 PM -
An Illustration of the Impact of Confounding Bias On Economic Evaluations in the Context of Real-World Evaluations
Mar 10, 2025, 14:00 PM
